STRO vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

STRO

39.9
AI Score
VS
CBIO Wins

CBIO

47.9
AI Score

Investment Advisor Scores

STRO

40score
Recommendation
SELL

CBIO

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric STRO CBIO Winner
Revenue 24.36M 1.04M STRO
Net Income -77.02M -48.12M CBIO
Net Margin -316.1% -4631.4% STRO
Operating Income -59.54M -51.09M CBIO
ROE 74.5% -29.5% STRO
ROA -39.6% -26.3% CBIO
Total Assets 194.46M 182.76M STRO
Cash 54.34M 171.59M CBIO
Current Ratio 3.32 9.66 CBIO

Relative Price Performance (Last 90 Days)

STRO 1M: -7.7% · 3M: -52.3% CBIO 1M: +8.2% · 3M: -16.0%

Current Technical Phase

STRO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -26.4%), weak momentum, RSI 41

RSI (14): 41.4 · Price: $10.17

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.0 · Price: $13.97

Fundamentals Snapshot

Metric STRO CBIO
Market Cap — —
Forward P/E -1.7 -5.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.8% 0.0%
Gross Margin -2.2% 1.0%
Operating Margin -3.0% -14.3%
EPS -17.28 -7.63
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CBIO is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.